Study Overview (The Australian National University)

Description: A multicenter, randomized, parallel-group, single-blind clinical trial evaluating the efficacy and safety of repeated low-level red-light (RLRL) therapy for myopia control in children.

Source: PubMed

Summary:

• Participants: 264 children aged 8–13 years with myopia ranging from -1.00 to -5.00 diopters.
• Intervention:
  • RLRL Group: Received RLRL therapy (650 nm, ~1600 lux) for 3 minutes twice daily, 5 days per week, at home under parental supervision.
  • Control Group: Wore single-vision spectacles (SVS).
• Methods: Axial length and spherical equivalent refraction (SER) were measured at baseline, and at 1, 3, 6, and 12 months.
• Conclusion: Repeated low-level red-light therapy shows promise as an alternative treatment for myopia control in children, significantly slowing axial elongation and SER progression, with good user acceptability and no documented functional or structural damage.